About 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide
5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide (PubChem CID 3040561) has the molecular formula C15H31BrN2O2
and a molecular weight of 351.33 g/mol. Its IUPAC name is 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide.
Analyze 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide?
The IUPAC name of 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide (CID 3040561) is 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide.
What is the SMILES notation for 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide?
The canonical SMILES for 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide is Br.CCCN1CC(CN(CC(C)C)CC(C)C)OC1=O.
What is the InChIKey of 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide?
The InChIKey is BACOEHCKWXVCBF-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H30N2O2.BrH/c1-6-7-17-11-14(19-15(17)18)10-16(8-12(2)3)9-13(4)5;/h12-14H,6-11H2,1-5H3;1H.
What are the key properties of 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide?
5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide has a molecular weight of 351.33 g/mol, XLogP of 3.41, 8 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[[bis(2-methylpropyl)amino]methyl]-3-propyl-1,3-oxazolidin-2-one;hydrobromide is sourced from PubChem (CID 3040561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).